Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF100.00.
According to TipRanks, Papadakis is a 4-star analyst with an average return of 5.4% and a 54.35% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and BioNTech SE.
In addition to Deutsche Bank , Novartis AG also received a Hold from TD Cowen’s Steve Scala in a report issued on November 11. However, on November 14, UBS maintained a Buy rating on Novartis AG (Six Swiss: NOVN).
The company has a one-year high of CHF102.72 and a one-year low of CHF83.63. Currently, Novartis AG has an average volume of 2.93M.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Novartis AG (NOVN) Company Description:
